A road map for the treatment of pediatric diffuse midline glioma

- Koschmann, Carl, Al-Holou, Wajd N., Clausen, Madison, Dang, Derek, Doherty, Robert, Duchatel, Ryan, Dun, Matthew, Filbin, Mariella, Franson, Andrea, Galban, Stefanie, Garcia Moure, Marc, Garton, Hugh, Alonso, Marta M., Gowda, Pruthvi, Marques, JG, Hawkins, C, Heath, A, Hulleman, E, Ji, S, Jones, C, Kilburn, L, Kline, C, Koldobskiy, MA, Anastas, Jamie, Lim, D, Lowenstein, PR, Lu, QR, Lum, J, Mack, S, Magge, S, Marini, B, Martin, D, Marupudi, N, Messinger, D, Bandopadhayay, Pratiti, Mody, R, Morgan, M, Mota, M, Muraszko, K, Mueller, S, Natarajan, SK, Nazarian, J, Niculcea, M, Nuechterlein, N, Okada, H, Barron, Tara, Opipari, V, Pai, MP, Pal, S, Peterson, E, Phoenix, T, Prensner, JR, Pun, M, Raju, GP, Reitman, ZJ, Resnick, A, Becher, Oren, Rogawski, D, Saratsis, A, Sbergio, SG, Souweidane, M, Stafford, JM, Tzaridis, T, Venkataraman, S, Vittorio, O, Wadden, J, Wahl, D, Cartaxo, Rodrigo, Wechsler-Reya, RJ, Yadav, VN, Zhang, X, Zhang, Q, Venneti, S, Castro, Maria G., Chung, Chan

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma

- Duchatel, Ryan J., Jackson, Evangeline R., Kearney, Padraic S., Jamaluddin, M. Fairuz B., Douglas, Alicia M., Beitaki, Tyrone, McEwen, Holly P., Persson, Mika L., Hocke, Emily A., Jain, Vaibhav, Aksu, Michael, Manning, Elizabeth E., Parackal, Sarah G., Murray, Heather C., Verrills, Nicole M., Hua, Susan, Cairns, Murray J., Alvaro, Frank, Dayas, Christopher V., Dun, Matthew D., Hua, S, de Bock, CE, Colino-Sanguino, Y, Kiltschewskij, Dylan, Valdes-Mora, F, Tsoli, M, Ziegler, DS, Cairns, MJ, Raabe, EH, Vitanza, NA, Hulleman, E, Phoenix, TN, Koschmann, C, Alvaro, F, Findlay, Izac J., Dayas, CV, Tinkle, CL, Wheeler, H, Whittle, JR, Eisenstat, DD, Firestein, R, Mueller, S, Valvi, S, Hansford, JR, Ashley, DM, Mannan, Abdul, Gregory, SG, Kilburn, LB, Nazarian, J, Cain, JE, Dun, MD, Staudt, Dilana E., Thomas, Bryce C., Germon, Zacary P., Laternser, Sandra

ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma

- Jackson, Evangeline R., Duchatel, Ryan J., Le Grand, Marion, Kearney, Padraic S., Douglas, Alicia M., Findlay, Izac J., Germon, Zacary P., McEwen, Holly P., Beitaki, Tyrone S., Patabendige, Adjanie, Skerrett-Byrne, David A., Nixon, Brett, Staudt, Dilana E., Smith, Nathan D., Day, B, Manoharan, N, Nagabushan, S, Hansford, JR, Govender, D, McCowage, GB, Firestein, R, Howlett, M, Endersby, R, Persson, Mika L., Gottardo, NG, Alvaro, F, Waszak, SM, Larsen, MR, Colino-Sanguino, Y, Valdés-Mora, F, Rakotomalala, A, Meignan, S, Pasquier, E, Andre, N, Mannan, Abdul, Hulleman, E, Eisenstat, DD, Vitanza, NA, Nazarian, J, Koschmann, C, Mueller, S, Cain, JE, Dun, MD, Yadavilli, Sridevi, Parackal, Sarah, Game, Shaye, Chong, Wai Chin, Jayasekara, W. Samantha N.